Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AstraZeneca
AstraZeneca
FDA clears narrow use of Lynparza in prostate cancer, continuing ‘shift’ on PARP drugs
BioPharma Dive
Thu, 06/1/23 - 11:53 am
AstraZeneca
Merck
Lynparza
prostate cancer
FDA
Liberate Bio taps former AZ drug-delivery head for CEO post
Medical Marketing and Media
Thu, 06/1/23 - 11:45 am
Liberate Bio
Pharma CEOs
AstraZeneca
Shawn Davis
AstraZeneca drops Skyrizi rival after seeing R&D timeline spiral
Fierce Biotech
Thu, 06/1/23 - 11:41 am
AstraZeneca
IBD
AbbVie
JNJ
brazikumab
Skyrizi
Stelara
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
FDA
Albireo Pharma
Aldeyra Therapeutics
Alvotech
Amneal Pharmaceuticals
Argenx
ARS Pharmaceuticals
AstraZeneca
Bayer
Bio-Thera Solutions
Biogen
BioMarin Pharmaceutical
Bristol Myers Squibb
Eisai
Eton Pharmaceuticals
F2G
Fabre-Kramer Pharmaceuticals
Fresenius
GSK
Intercept Pharmaceuticals
Ipsen
Ironwood Pharmaceuticals
Merck
Novaliq
Pfizer
Regeneron
Roche
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Takeda
Teva Pharmaceutica
UCB Pharma
AstraZeneca reports positive results from endometrial cancer therapy trial
Clinical Trials Arena
Mon, 05/29/23 - 12:24 pm
AstraZeneca
endometrial cancer
clinical trials
Imfinzi
Lynparza
AstraZeneca's drug combo shows positive results in late-stage cancer trial
Reuters
Fri, 05/26/23 - 10:09 am
ASCO 2023
AstraZeneca
Imfinzi
Lynparza
endometrial cancer
AstraZeneca Deepens Gene Editing Capabilities with Revvity Partnership
BioSpace
Thu, 05/18/23 - 11:21 am
AstraZeneca
Revvity
gene editing
cell therapy
AstraZeneca's Tagrisso, chemo combination shows promise in lung cancer trial
Yahoo/Reuters
Wed, 05/17/23 - 11:16 am
AstraZeneca
clinical trials
Tagrisso
AstraZeneca is third member to leave PhRMA in five months
Stat
Tue, 05/16/23 - 12:03 pm
AstraZeneca
lobbying
PhRMA
AstraZeneca Expands ADC Portfolio with $600M Deal with LaNova
BioSpace
Mon, 05/15/23 - 06:35 pm
AstraZeneca
antibody-drug conjugate
LaNova Medicines
The waxing and waning of the speedy approval
EP Vantage
Mon, 05/15/23 - 09:58 am
FDA
drug approvals
accelerated approvals
AbbVie
AstraZeneca
Bayer
Bristol Myers Squibb
JNJ
Merck
Merck KGaA
Novartis
Pfizer
Farxiga’s approval for expanded use highlights potential to differentiate in HF space
Clinical Trials Arena
Fri, 05/12/23 - 11:42 am
AstraZeneca
Farxiga
heart failure
2023’s biggest launches: the story so far
EP Vantage
Fri, 05/12/23 - 10:19 am
drug launches
AbbVie
Almirall
Apellis Pharmaceuticals
Astellas
AstraZeneca
Biogen
CRISPR Therapeutics
Daiichi Sankyo
Eli Lilly
Genmab
GSK
Iveric Bio
Pfizer
Roche
SAGE Therapeutics
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Vertex Pharmaceuticals
Sanofi, AstraZeneca Report Promising RSV Pediatric Data Ahead of Pfizer Adcomm
BioSpace
Fri, 05/12/23 - 10:16 am
Sanofi
AstraZeneca
RSV
antibodies
infants
clinical trials
A blockbuster year could be building
EP Vantage
Wed, 05/10/23 - 09:55 am
AbbVie
Amgen
AstraZeneca
Bristol Myers Squibb
Daiichi Sankyo
Eli Lilly
Gilead Sciences
Horizon Therapeutics
Merck
Moderna Therapeutics
Novartis
Novo Nordisk
Pfizer
Regeneron
Roche
Sanofi
Farxiga Approval Expands Use to More Patients With Heart Failure
eMPR
Tue, 05/9/23 - 11:28 pm
AstraZeneca
Farxiga
FDA
Biopharma Bets Big on Antibody-Drug Conjugates
BioSpace
Mon, 05/8/23 - 10:20 am
antibody-drug conjugate
Merck
Seagen
M&A
AstraZeneca
BioNTech
Bristol Myers Squibb
AstraZeneca, Pfizer Top 2023 Pharma List for Invention and Innovation
BioSpace
Sun, 05/7/23 - 10:23 pm
reputation
AstraZeneca
Pfizer
innovation
IDEA Pharma
AstraZeneca scraps pact with Riva-led Transgene in further blow to oncolytic viruses
Fierce Biotech
Fri, 05/5/23 - 10:18 am
AstraZeneca
oncolytic viruses
Transgene
Bristol Myers accuses AstraZeneca of infringing patent on cancer blockbuster Opdivo—again
Fierce Pharma
Tue, 05/2/23 - 11:30 pm
Bristol Myers Squibb
Opdivo
patents
legal
AstraZeneca
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »